Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Preliminary Study of Prevalence for Bladder Cancer in Isfahan Province, Iran Publisher



Mazdak H1, 2 ; Toloughamari Z1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Isfahan Kidney Transplantation Research Center, Alzahra Research Centers, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Urology, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Arab Journal of Urology Published:2018


Abstract

Objectives: To clarify period prevalence (PP), incidence rate (Ir), and reported mortality for patients with bladder cancer (BC) in Isfahan Province/Iran, as BC is the most common cancer of the urinary tract in Iran and other parts of the world. Patients and methods: Data from 21 March 2011 to 3 March 2015 was obtained from the Isfahan Cancer Registry. BC was distinguished by the related established topography code (C67). Ir and PP were calculated and expressed per 100 000 persons. Results: In all, 279 females and 1376 males were identified. For the total population the PP was calculated as 33.2. This value corresponded to a PP of 54.4 for males and 11.4 for females (P < 0.001). Histologically, 63% of patients had invasive BC. Irs versus mortality rates were calculated for each year, i.e. 2011–2012, 2012–2013, 2013–2014, and 2014–2015, as 7.7 vs 0.56, 8.1 vs 0.74, 7.4 vs 0.98, and 9.9 vs 0.84, respectively. The mean (SD, range) age of the patients was 65.2 (13.9, 3–100) years. In relation to the age of the study population, BC occurred in 12% of patients aged <50 years and in 15% of those aged ≥80 years. Conclusion: The PP for BC in the male population was 4.8-times higher than females. There was a 28.6% increase in the Ir over the study period. Further study concerning environmental exposure, genetic factors, job-related exposure to various chemical carcinogens, and geographical distribution in Isfahan and its’ rural provinces would seem to be valuable. © 2017 Arab Association of Urology
1. Investigation of Bladder Cancer Incidence in Isfahan, Iran, Tehran University Medical Journal (2019)
4. Cancers of Urinary System; Prevalence, Demographic, Jundishapur Journal of Chronic Disease Care (2019)
6. Cancer Epidemiology and Trends in Sistan and Baluchestan Province, Iran, Medical Journal of the Islamic Republic of Iran (2015)
7. Bladder Cancer in Iran: Geographical Distribution and Risk Factors, International Journal of Cancer Management (2017)
8. Epidemiology and Trend of Cancers in the Province of Kerman: Southeast of Iran, Asian Pacific Journal of Cancer Prevention (2015)
Experts (# of related papers)
Other Related Docs
12. Survival of Rectal Cancer in Yazd, Iran, Asian Pacific Journal of Cancer Prevention (2014)
15. Prevalence of Lung Cancer in Isfahan Province, Iran, Journal of the Egyptian National Cancer Institute (2018)
16. Association Between the High Risk Occupations and Bladder Cancer in Iran: A Case-Control Study, International Journal of Occupational Medicine and Environmental Health (2013)
18. Trends in Colorectal Cancer Incidence in Iran, Journal of Mazandaran University of Medical Sciences (2015)
19. The Economic Cost of Cancer Treatment in Iran, Journal of Education and Health Promotion (2023)
21. Prevalence of Stomach Cancer in Isfahan Province, Iran, The Gulf journal of oncology (2018)
24. Temporal Trends of Incidence of Colorectal Cancer in Isfahan, Iran, 2000-2011, International Journal of Preventive Medicine (2018)
28. The Risk Factors of Prostate Cancer: A Multicentric Case-Control Study in Iran, Asian Pacific Journal of Cancer Prevention (2007)
38. Iranian Women Diagnosed With Breast Cancer a Decade Earlier Than British Women?, Journal of Kerman University of Medical Sciences (2022)
39. Iran National Cancer Control Program (Irnccp): Goals, Strategies, and Programs, Medical Journal of the Islamic Republic of Iran (2022)